NCT03519178 2025-11-14A Study of PF-06873600 in People With CancerPfizerPhase 1/2 Terminated155 enrolled 44 charts
NCT02751528 2025-01-13QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast CancerNantBioScience, Inc.Phase 1 Terminated3 enrolled 10 charts